Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3801
Fossil Group
FOSL
$402M
| $498K | ﹤0.01% |
132,459
+54,862
| +71% | +$155K |
2013 Q2
50 quarters
|
|
3802
iShares iBonds Dec 2033 Term Corporate ETF
IBDY
$1.15B
| $497K | ﹤0.01% |
19,019
| – | – |
2025 Q3
1 quarter
|
|
3803
Plumas Bancorp
PLBC
$435M
| $497K | ﹤0.01% |
11,116
+1,651
| +17% | +$70.8K |
2023 Q1
11 quarters
|
|
3804
Titan Machinery
TITN
$598M
| $495K | ﹤0.01% |
32,914
+3,553
| +12% | +$57.2K |
2013 Q2
50 quarters
|
|
|
ALMU
3805
Aeluma Inc
ALMU
$253M
| $494K | ﹤0.01% |
28,748
+14,841
| +107% | +$234K |
2025 Q2
2 quarters
|
|
|
PAL
3806
Proficient Auto Logistics
PAL
$99.9M
| $492K | ﹤0.01% |
51,022
+15,464
| +43% | +$121K |
2024 Q3
5 quarters
|
|
3807
Teleflex
TFX
$5.26B
| $492K | ﹤0.01% |
4,028
+708
| +21% | +$85.8K |
2013 Q2
50 quarters
|
|
3808
Lyell Immunopharma
LYEL
$227M
| $491K | ﹤0.01% |
15,967
+14,775
| +1,240% | +$331K |
2022 Q1
15 quarters
|
|
|
PPIH
3809
Perma-Pipe International
PPIH
$261M
| $491K | ﹤0.01% |
16,184
+14,505
| +864% | +$398K |
2025 Q3
1 quarter
|
|
3810
CALL
Elevance Health
ELV
$83.8B
| $491K | ﹤0.01% |
1,400
| – | – |
2023 Q3
9 quarters
|
|
3811
Coherus Oncology
CHRS
$179M
| $491K | ﹤0.01% |
345,573
+52,381
| +18% | +$76.3K |
2014 Q4
44 quarters
|
|
3812
Occidental Petroleum Corp Warrants
OXY.WS
$34B
| $489K | ﹤0.01% |
25,403
-221
| -0.9% | -$4.39K |
2022 Q1
15 quarters
|
|
|
DENN
3813
DELISTED
Denny's
DENN
| $489K | ﹤0.01% |
78,597
+7,656
| +11% | +$43.4K |
2013 Q2
50 quarters
|
|
3814
CALL
Republic Services
RSG
$64.2B
| $487K | ﹤0.01% |
2,300
-100
| -4% | -$21.5K |
2025 Q3
1 quarter
|
|
3815
Xperi
XPER
$265M
| $487K | ﹤0.01% |
83,178
+15,128
| +22% | +$94.9K |
2022 Q4
12 quarters
|
|
3816
Simulations Plus
SLP
$374M
| $485K | ﹤0.01% |
26,631
+2,141
| +9% | +$37.6K |
2023 Q1
11 quarters
|
|
3817
Puma Biotechnology
PBYI
$491M
| $485K | ﹤0.01% |
81,434
+1,553
| +2% | +$8.25K |
2016 Q3
37 quarters
|
|
3818
Ascent Industries
ACNT
$124M
| $484K | ﹤0.01% |
29,881
+2,107
| +8% | +$29K |
2024 Q4
4 quarters
|
|
|
VOXR
3819
Vox Royalty Corp
VOXR
$350M
| $484K | ﹤0.01% |
102,016
+38,225
| +60% | +$173K |
2025 Q2
2 quarters
|
|
3820
Cabaletta Bio
CABA
$339M
| $483K | ﹤0.01% |
220,696
+217,613
| +7,058% | +$539K |
2022 Q1
15 quarters
|
|
3821
American Vanguard Corp
AVD
$51.3M
| $482K | ﹤0.01% |
126,269
+4,391
| +4% | +$20.5K |
2013 Q2
50 quarters
|
|
3822
CALL
Joby Aviation
JOBY
$5.93B
| $482K | ﹤0.01% |
36,500
-13,500
| -27% | -$207K |
2025 Q2
2 quarters
|
|
3823
Electromed
ELMD
$233M
| $479K | ﹤0.01% |
16,464
+2,147
| +15% | +$56.3K |
2024 Q3
5 quarters
|
|
3824
American Coastal Insurance
ACIC
$441M
| $479K | ﹤0.01% |
37,920
+3,547
| +10% | +$42.8K |
2023 Q2
10 quarters
|
|
3825
Celanese
CE
$4.85B
| $478K | ﹤0.01% |
11,316
-6,609
| -37% | -$270K |
2013 Q2
50 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.